Cargando…
Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study
BACKGROUND: Patent ductus arteriosus (PDA) is a common congenital heart disease. Interventional therapy is an important treatment for PDA. Nevertheless, few studies have investigated the safety and effectiveness of interventional therapy for infants (age, 0–36 months) with PDA and moderate-to-severe...
Autores principales: | Shu, Yue, Guo, Yilong, Wang, Xiaoqi, Zhou, Dexing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178739/ https://www.ncbi.nlm.nih.gov/pubmed/32321548 http://dx.doi.org/10.1186/s13019-020-01110-5 |
Ejemplares similares
-
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020) -
Management of Patent Ductus Arteriosus in Premature Infants in 2020
por: Parkerson, Sarah, et al.
Publicado: (2021) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021) -
Case of Patent Ductus Arteriosus
por: Harrington, Archibald W.
Publicado: (1914)